284 related articles for article (PubMed ID: 22562592)
1. Effect of Angiotensin-converting enzyme inhibitors and Angiotensin receptor antagonists in atherosclerosis prevention.
Patarroyo Aponte MM; Francis GS
Curr Cardiol Rep; 2012 Aug; 14(4):433-42. PubMed ID: 22562592
[TBL] [Abstract][Full Text] [Related]
2. Optimal antagonism of the Renin-Angiotensin-aldosterone system: do we need dual or triple therapy?
Werner C; Pöss J; Böhm M
Drugs; 2010 Jul; 70(10):1215-30. PubMed ID: 20568830
[TBL] [Abstract][Full Text] [Related]
3. Renin Angiotensin Aldosterone System Inhibitors in Hypertension: Is There Evidence for Benefit Independent of Blood Pressure Reduction?
Bavishi C; Bangalore S; Messerli FH
Prog Cardiovasc Dis; 2016; 59(3):253-261. PubMed ID: 27777044
[TBL] [Abstract][Full Text] [Related]
4. It is time to reconsider the cardiovascular protection afforded by RAAS blockade -- overview of RAAS systems.
Tsukamoto O; Kitakaze M
Cardiovasc Drugs Ther; 2013 Apr; 27(2):133-8. PubMed ID: 22147138
[TBL] [Abstract][Full Text] [Related]
5. Should ACE inhibitors and ARBs be used in combination in children?
Stotter BR; Ferguson MA
Pediatr Nephrol; 2019 Sep; 34(9):1521-1532. PubMed ID: 30112656
[TBL] [Abstract][Full Text] [Related]
6. Blockade of the renin-angiotensin-aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: a systematic review and meta analysis of randomized controlled trials.
Khatib R; Joseph P; Briel M; Yusuf S; Healey J
Int J Cardiol; 2013 Apr; 165(1):17-24. PubMed ID: 22421406
[TBL] [Abstract][Full Text] [Related]
7. Effects of Renin-Angiotensin-Aldosterone System Blockade in Patients with End-Stage Renal Disease.
Slomka T; Lennon ES; Akbar H; Gosmanova EO; Bhattacharya SK; Oliphant CS; Khouzam RN
Am J Med Sci; 2016 Mar; 351(3):309-16. PubMed ID: 26992264
[TBL] [Abstract][Full Text] [Related]
8. The evolving landscape of RAAS inhibition: from ACE inhibitors to ARBs, to DRIs and beyond.
Epstein BJ; Leonard PT; Shah NK
Expert Rev Cardiovasc Ther; 2012 Jun; 10(6):713-25. PubMed ID: 22894628
[TBL] [Abstract][Full Text] [Related]
9. The renin-angiotensin-aldosterone system blockade and arterial stiffness in renal transplant recipients - a cross-sectional prospective observational clinical study.
Heleniak Z; Illersperger S; Brakemeier S; Bach P; Dębska-Ślizień A; Budde K; Halleck F
Acta Biochim Pol; 2020 Dec; 67(4):613-622. PubMed ID: 33332078
[TBL] [Abstract][Full Text] [Related]
10. Current strategies to achieve further cardiac and renal protection through enhanced renin-angiotensin-aldosterone system inhibition.
Alfie J; Aparicio LS; Waisman GD
Rev Recent Clin Trials; 2011 May; 6(2):134-46. PubMed ID: 21241234
[TBL] [Abstract][Full Text] [Related]
11. Cardiorenal protection during chronic renin-angiotensin-aldosterone system suppression: evidences and caveats.
Ruiz-Hurtado G; Ruilope LM
Eur Heart J Cardiovasc Pharmacother; 2015 Apr; 1(2):126-31. PubMed ID: 27533982
[TBL] [Abstract][Full Text] [Related]
12. Blocking the RAAS at different levels: an update on the use of the direct renin inhibitors alone and in combination.
Cagnoni F; Njwe CA; Zaninelli A; Ricci AR; Daffra D; D'Ospina A; Preti P; Destro M
Vasc Health Risk Manag; 2010 Aug; 6():549-59. PubMed ID: 20730071
[TBL] [Abstract][Full Text] [Related]
13. Effect of renin angiotensin blockers on angiotensin converting enzyme 2 level in cardiovascular patients.
Farid Fahmy S; El Derany MO; Khorshid H; Saleh A; El-Demerdash E
BMC Pharmacol Toxicol; 2023 Apr; 24(1):24. PubMed ID: 37060024
[TBL] [Abstract][Full Text] [Related]
14. [The effect of ARB on prevention of atherosclerosis].
Aoyama T; Minatoguchi S
Nihon Rinsho; 2011 Jan; 69(1):92-9. PubMed ID: 21226267
[TBL] [Abstract][Full Text] [Related]
15. RAAS inhibition and the course of Alport syndrome.
Savva I; Pierides A; Deltas C
Pharmacol Res; 2016 May; 107():205-210. PubMed ID: 26995302
[TBL] [Abstract][Full Text] [Related]
16. A Modern History RAAS Inhibition and Beta Blockade for Heart Failure to Underscore the Non-equivalency of ACEIs and ARBs.
Hyman DA; Siebert VR; Birnbaum GD; Alam M; Birnbaum Y
Cardiovasc Drugs Ther; 2020 Apr; 34(2):215-221. PubMed ID: 32219664
[TBL] [Abstract][Full Text] [Related]
17. Renin-angiotensin-aldosterone system inhibitors in heart failure.
Shearer F; Lang CC; Struthers AD
Clin Pharmacol Ther; 2013 Oct; 94(4):459-67. PubMed ID: 23852393
[TBL] [Abstract][Full Text] [Related]
18. Impact of renin-angiotensin system inhibitors on mortality and major cardiovascular endpoints in hypertension: A number-needed-to-treat analysis.
Brugts JJ; van Vark L; Akkerhuis M; Bertrand M; Fox K; Mourad JJ; Boersma E
Int J Cardiol; 2015 Feb; 181():425-9. PubMed ID: 25569271
[TBL] [Abstract][Full Text] [Related]
19. Does blockade of the Renin-Angiotensin-aldosterone system slow progression of all forms of kidney disease?
Lattanzio MR; Weir MR
Curr Hypertens Rep; 2010 Oct; 12(5):369-77. PubMed ID: 20703958
[TBL] [Abstract][Full Text] [Related]
20. [Inflammation and atherosclerosis: the role of Renin-Angiotensin system and its inhibition].
Partigulova AS; Naumov VG
Kardiologiia; 2010; 50(10):50-5. PubMed ID: 21118180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
